The global prevalence of COVID-19 disease and the overwhelming increase in death toll urge scientists to discover new effective drugs. Although the drug discovery process is a …
Coronavirus disease 2019 (COVID-19) pandemic has infected billions and has killed millions of people. Despite the advancement in drugs and vaccines, the COVID-19 …
M Dutta, AM Tareq, A Rakib, S Mahmud, SA Sami… - Biology, 2021 - mdpi.com
Simple Summary Molecular docking in conjunction with molecular dynamics simulation was accomplished as they extend an ample opportunity to screen plausible inhibitors of the main …
Since December 2019, coronavirus disease (COVID‐19) has claimed the lives of millions of people across the globe. To date, no medicine is available for the responsible virus SARS …
Various computational studies, including in silico ones, have identified several existing compounds that could serve as effective inhibitors of the SARS-CoV-2 main protease …
H Hadni, A Fitri, AT Benjelloun, M Benzakour… - Journal of the Indian …, 2022 - Elsevier
The 3CLpro main protease and the RDB spike (s) protein of SARS-CoV-2 are critical targets in the treatment of coronavirus 19 disease (COVID-19), as they are responsible for the …
Melissa officinalis (Lamiaceae) was used to treat multiple human afflictions. Literary works demonstrated that it has many biological activities. Today's research aims to recognise …
P Kar, NR Sharma, B Singh, A Sen… - Journal of Biomolecular …, 2021 - Taylor & Francis
The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has rattled global public health, with researchers struggling to find specific therapeutic solutions. In this …
The COVID-19 pandemic has claimed more than a million lives worldwide within a short time span. Due to the unavailability of specific antiviral drugs or vaccine, the infections are …